NEW ORLEANS —In this Healio Video Perspective from the Eyecelerator meeting, Jag Dosanjh, senior vice president of U.S. eye care for Allergan, discusses activity within the company.
Dosanjh touches on recent acquisitions and the FDA approval of Vuity (pilocarpine HCl ophthalmic solution 1.25%).